131 related articles for article (PubMed ID: 16026738)
1. Prognostic features of multiple myeloma.
San Miguel JF; García-Sanz R
Best Pract Res Clin Haematol; 2005; 18(4):569-83. PubMed ID: 16026738
[TBL] [Abstract][Full Text] [Related]
2. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and staging in multiple myeloma.
Fonseca R; San Miguel J
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1115-40, ix. PubMed ID: 17996591
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley JF; Rahemtulla A
Bone Marrow Transplant; 2006 Apr; 37(8):731-7. PubMed ID: 16501593
[TBL] [Abstract][Full Text] [Related]
5. Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Stella-Holowiecka B; Czerw T; Holowiecka-Goral A; Giebel S; Wojnar J; Holowiecki J
Transplant Proc; 2007 Nov; 39(9):2893-7. PubMed ID: 18022010
[TBL] [Abstract][Full Text] [Related]
6. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.
Mehta J; Singhal S
Bone Marrow Transplant; 2007 Dec; 40(12):1101-14. PubMed ID: 17680020
[TBL] [Abstract][Full Text] [Related]
8. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Brinker BT; Waller EK; Leong T; Heffner LT; Redei I; Langston AA; Lonial S
Cancer; 2006 May; 106(10):2171-80. PubMed ID: 16598756
[TBL] [Abstract][Full Text] [Related]
9. Stem-cell transplantation in multiple myeloma.
Harousseau JL; Moreau P; Attal M; Facon T; Avet-Loiseau H
Best Pract Res Clin Haematol; 2005; 18(4):603-18. PubMed ID: 16026740
[TBL] [Abstract][Full Text] [Related]
10. Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
Br J Haematol; 2008 Apr; 141(2):205-11. PubMed ID: 18318761
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma--an update on diagnosis and treatment.
Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K
Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123
[TBL] [Abstract][Full Text] [Related]
12. [Multiple myeloma. Role of prognostic factors and staging in a therapeutic program].
Bolis S; Bregani ER; Rossini F; Casaroli I; Lanzi E; Maffè P; Baldicchi L; Borin L; Mingozzi S; Tripputi P
Recenti Prog Med; 1994 Jan; 85(1):49-55. PubMed ID: 8184181
[TBL] [Abstract][Full Text] [Related]
13. [The importance of autologous transplantation in multiple myeloma].
Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
Mateos MV; Hernández JM; Hernández MT; Gutiérrez NC; Palomera L; Fuertes M; Garcia-Sanchez P; Lahuerta JJ; de la Rubia J; Terol MJ; Sureda A; Bargay J; Ribas P; Alegre A; de Arriba F; Oriol A; Carrera D; García-Laraña J; García-Sanz R; Bladé J; Prósper F; Mateo G; Esseltine DL; van de Velde H; San Miguel JF
Haematologica; 2008 Apr; 93(4):560-5. PubMed ID: 18322252
[TBL] [Abstract][Full Text] [Related]
16. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of multiple myeloma].
Paule B
Ann Med Interne (Paris); 1997; 148(8):534-41. PubMed ID: 9538400
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma: clinical evaluation of plasma cell lymphoproliferative disorders and initial management.
Zulian GB
Semin Hematol; 1997 Jan; 34(1 Suppl 1):29-39. PubMed ID: 9122744
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
Am J Hematol; 2008 Aug; 83(8):614-7. PubMed ID: 18429054
[TBL] [Abstract][Full Text] [Related]
20. Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
Harousseau JL; Avet-Loiseau H; Attal M; Charbonnel C; Garban F; Hulin C; Michallet M; Facon T; Garderet L; Marit G; Ketterer N; Lamy T; Voillat L; Guilhot F; Doyen C; Mathiot C; Moreau P
J Clin Oncol; 2009 Dec; 27(34):5720-6. PubMed ID: 19826130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
